DE EN
DE EN

Press releases

Stay informed about the latest developments and research results of the DZNE. We are available to answer press inquiries over here.

Image shows gait analysis in clinical research.
European Partnership between Academia and Pharma to Study SCA3 Ataxia
A European research consortium led by DZNE will be investigating the neurodegenerative disease “Spinocerebellar Ataxia Type 3” (SCA3) in collaboration with the French pharmaceutical company Servier Laboratories.
symbol image mri
Alzheimer’s: Protective Immune Cells Active Decades Before Symptom Onset
In individuals with a genetic predisposition to Alzheimer’s disease, the immune cells of the brain – the “microglia” – start exerting a protective effect up to two decades before the first symptoms appear.
Cross-section through the human retina showing its different layers.
The Retina as a Potential Biomarker for Reduced Brain Matter
A study by DZNE and the University Hospital Bonn suggests that assessments of the eye’s retina could help to detect a loss of brain substance, i. e. “brain atrophy”.
Research lab, symbol image,
Alzheimer‘s: Researchers Investigate Drug Candidates against „Tau Aggregates“
DZNE scientist Markus Zweckstetter has been awarded 150,000 euros by the European Research Council to test potential drugs against Alzheimer’s disease in laboratory studies.
Microglia cells under the microscope.
Highly Responsive Immune Cells Seem to be Beneficial for the Brain
Findings by DZNE researchers and partners support the view that hyperactive immune cells in the brain can have a protective effect in the course of neurodegenerative diseases.
Symbolic image, not for editorial use.
A Nationwide Study: Does PET Help with “Unclear Dementia”?
A consortium led by DZNE has been tasked with investigating whether patients with “dementia of unclear etiology” benefit from examination of the brain using amyloid PET.
State-of-the-art Brain Scanner for Dementia Research Starts Operation in Rostock
The scanner is intended in particular for research into the early diagnosis and treatment of dementia.
Symbol image of antibodies and viruses.
Corona: New Insights into Antibody Response against Viral Variants
In the journal “Science”, researchers from DZNE and Charité present new findings on the immune response against SARS-CoV-2.
Symbolic image
Alzheimer’s Research: Inflammatory Markers Are Conspicuous at an Early Stage
Long before the onset of dementia, there is evidence for increased activity of the brain’s immune system. Researchers from DZNE and the University Hospital Bonn come to this conclusion based on a study of more than 1,000 older adults.
Symbolic images showing DNA data
Around 1.5 Million Euros for Bonn Dementia Researcher
Ahmad Aziz, scientist at DZNE’s Bonn site, has been awarded a “Starting Grant” from the European Research Council (ERC) worth around 1.5 million euros. With this funding, he aims to investigate the extent to which certain patterns in the genetic code contribute…